Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Inovio Pharmaceuticals Inc’s current trading price is -84.23% away from its 52-week high, while its distance from the 52-week low is 26.54%. The stock’s price range over this period has fluctuated between $0.32 and $2.60. The company, operating within the financial sector, had a trading volume of approximately 2.36 million for the day, which was noticeably lower than the average daily share volume of 3.43 million over the last 3 months.
The stock price for Inovio Pharmaceuticals Inc (INO) currently stands at $0.41. The stock experienced a substantial increase in the last session, hitting $0.4297 after starting at $0.3827. The stock’s lowest price was $0.381 before closing at $0.38.
In terms of market performance, Inovio Pharmaceuticals Inc had a fairly uneven. The highest value for the stock in the past year was $2.60 on 11/18/22, and the lowest value was recorded at $0.32 on 11/10/23.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Inovio Pharmaceuticals Inc (INO) has experienced a quarterly decline of -7.16% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 111.93M and boasts a workforce of 184 employees.
Inovio Pharmaceuticals Inc: What Analysts Are Saying
As of right now, 0 analyst is rating Inovio Pharmaceuticals Inc as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.4425, with a change in price of +0.0115. Similarly, Inovio Pharmaceuticals Inc recorded 3,924,069 in trading volume during the last 100 days, posting a change of +2.89%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for INO stands at 0.22. Similarly, the long-term debt-to-equity ratio is also 0.08.
INO Stock Stochastic Average
Today’s raw stochastic average for Inovio Pharmaceuticals Inc over the last 50 days is 31.93%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 54.26%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 40.15% and 28.18%, respectively.
INO Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price decrease of -73.72%. However, over the past six months, we’ve seen a stronger performance of -37.15%. The price of INO leaped by -11.49% over the last 30 days. And in the last five days, it has surged by 13.23%.